Navigation Links
Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use'
Date:3/14/2008

INDIANAPOLIS, March 14 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today called the assertions in a New York Times online article 'flat out wrong.' The Times report in question focused on the State of Alaska v. Eli Lilly and Company trial that is underway and attempted to interpret a 2003 email from John C. Lechleiter, Ph.D., currently Lilly's president and chief operating officer. About this email and the Times report, the company makes the following statement:

-- The Times article not only mischaracterized Dr. Lechleiter's email,

which the court deemed inadmissible, but significantly minimized

Lilly's perspective on this topic, resulting in a very skewed and

inaccurate article.

-- At the time of the email referenced (2003), Dr. Lechleiter was the

company's vice president of pharmaceutical products and corporate

development, overseeing the area of the company that is responsible for

developing new products and conducting late-stage clinical programs to

address the most pressing medical questions and also to ensure Lilly

made successful regulatory submissions. Importantly, he did not

oversee or direct promotional or marketing activities.

-- Additionally, in 2003, no atypical antipsychotic treatments were

approved by the FDA for children or adolescents suffering from

schizophrenia and bipolar disorder; yet physicians, desperate to

improve their young patients' lives, were already prescribing these

medicines, albeit, with limited information on their safety, efficacy

or dosing considerations in these special patient populations. Dr.

Lechleiter had just returned from a
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Statement of Bernadette Toomey, President and Chief Executive Officer, American Lung Association
2. Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement
3. Position Statement Regarding Lt. Gov. Paterson from Tara A. Cortes, Ph.D, RN President and CEO of Lighthouse International
4. Health Plan and Preferred Provider Network Communities Issue Joint Statement on Passage of Healthcare Simplification Act
5. Statement From Dr. Dipak Desai
6. Statement from American Water Works Association on Associated Press Story on Pharmaceuticals in Drinking Water
7. Empire Blue Cross Blue Shield Statement in Response to New York Attorney Generals Recent Subpoenas
8. United Mitochondrial Disease Foundation Statement on Vaccines, Autism and Mitochondrial Disease
9. AHIP Statement on House Passage of Mental Health Parity Legislation
10. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
11. Roche Statement Regarding Tamiflu U.S. Label Revision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... CT (PRWEB) December 15, 2014 Kathy ... the prestigious Women World Awards in the category of ... a gold award for her weekly career blog ... practical advice to help professionals elevate their talent and ... Her blog, named after her book Networking Ahead for ...
(Date:12/15/2014)... 15, 2014 In support of ... attention to restrictive state laws that may have ... this important area of public health policy. , ... the Integrity of Independent Review, contends that state ... independent peer review determinations can result in subpar ...
(Date:12/15/2014)... Bacteroides is becoming the indicator of choice ... more prevalent than coliforms, it cannot reproduce in the presence ... , Key Benefits of the new Bacteroides Sewage Screen:, ... Eliminates false positives from coliforms naturally occurring in the ... Maintain the same sampling method with results as ...
(Date:12/15/2014)... For the second year in a row, ... Coffees of 2014.” Bird Rock Coffee Roasters’ Sumatra Ulos Batak ... at number 10. This is the first year that any ... is ranked on quality, value, and other aspects, including certifications ... of 100, and at $17.99 for 12-ounces, was also the ...
(Date:12/15/2014)... Following on the heels of its successful and ... up for another round of holiday cheer. , The ... dispensaries, began the 2014 holiday shopping season with a ... , “We've picked up a lot of new ... CEO and founder, Ryan Fox. , And as Colorado ...
Breaking Medicine News(10 mins):Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2Health News:Colorado’s Grass Station Helps Holiday Shoppers Put Something Special under the Christmas Tree 2
... ... ... Coker has named David Booher as Vice President of Jackson & Coker,s Emergency Medicine ... very capable leader in our accounting and finance department, and his well-rounded abilities in other ...
... ... workplaces for top talent , ... Hudson, OH (PRWEB) September 2, 2009 -- Lexi-Comp, Inc., a leader in providing drug and ... Northeast Ohio,s 99 great workplaces for top talent. The Hudson-based, privately-owned company was founded ...
... , WASHINGTON, Sept. 2 The American ... Council for recommending a solid array of meaningful community actions ... Obesity. Overweight children have a 70 percent chance of ... rise nationwide, our youngsters have substantially greater risks for developing ...
... , , , REDMOND, Wash., Sept. ... senior living and assisted living communities ... of 425 magazine . In the first-ever "Best ... people, places and services. Aegis Living is always developing innovative ways to ...
... , BURBANK, Calif., Sept. 1 Warner Bros. Consumer ... partnership today to reach out to Hispanic mothers and promote healthy, ... The partnership will provide new and expecting mothers with fun, ... babies. Launching in celebration of Hispanic Heritage Month, a special ...
... Magazines that rank facilities don,t take all measurements into account ... make it onto the U.S. News & World Report ... perform well in some measurements regarding heart failure, researchers say. ... compares in the areas of heart failure mortality and readmission, ...
Cached Medicine News:Health News:Jackson & Coker Names David Booher Vice President of Emergency Medicine Recruitment 2Health News:Lexi-Comp, Inc. Receives NorthCoast 99 Honor 2Health News:Lexi-Comp, Inc. Receives NorthCoast 99 Honor 3Health News:Lexi-Comp, Inc. Receives NorthCoast 99 Honor 4Health News:Aegis Living Chosen as Best Retirement Facility in 2009 Best of 425 magazine 2Health News:Video: Renowned Health Expert Dra. Aliza Teams Up With Baby Looney Tunes To Promote Healthy, Happy Babies 2Health News:Video: Renowned Health Expert Dra. Aliza Teams Up With Baby Looney Tunes To Promote Healthy, Happy Babies 3Health News:Video: Renowned Health Expert Dra. Aliza Teams Up With Baby Looney Tunes To Promote Healthy, Happy Babies 4Health News:Government Best Source for U.S. Hospital Data, Study Finds 2
(Date:12/15/2014)... December 15, 2014 Investor-Edge has initiated ... ZGNX ), Eli Lilly and Company (NYSE: LLY ... SNY ), and Novartis AG (NYSE: ... accessed at: http://investor-edge.com/register . On Friday, December ... the Dow Jones Industrial Average lost 1.79%, to finish the ...
(Date:12/15/2014)... LONDON and BOSTON , ... the leading GPCR structure-guided drug discovery and development company, ... patents in the United States ... of these patents in the US significantly strengthens the ... the major pharmaceutical markets. The suite of ...
(Date:12/13/2014)... Ala. , Dec. 12, 2014 ... purchased the HiSeq X Ten sequencing system manufactured ... enable HudsonAlpha to produce and analyze genomic data ... stems from the Institute,s commitment to research programs ... The HiSeq X Ten provides unprecedented capacity, speed ...
Breaking Medicine Technology:Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 2HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system 3
... YORK, April 20, 2011 Reportlinker.com announces that a ... Successful Strategies for Drug Repositioning ... Introduction This report Highlights ... to drug development. The success of the approach is ...
... Sagent Pharmaceuticals (Nasdaq: SGNT ) announced the ... of the offering has been increased from the previously announced ... stock at a price to the public of $16.00 per ... NASDAQ Global Market on April 20, 2011 under the ticker ...
Cached Medicine Technology:Reportlinker Adds Successful Strategies for Drug Repositioning 2Reportlinker Adds Successful Strategies for Drug Repositioning 3Reportlinker Adds Successful Strategies for Drug Repositioning 4Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering 2
... is a hospital grade Nd: YAG laser ... precise, reliable means for performing posterior capsulotomy, ... can be used for the treatment of ... (posterior capsulotomy), and closed-angle glaucoma (iridotomy). , ...
... Laserex Ultra Q is the fundamental capsulotmy laser ... energy delivery and provides 2855% less energy in ... mJs in contemporary systems. This technology eliminates ... the risk of IOL pitting. , , ...
... a high-end, mobile ultrasound imaging system. Its ... tremendous amount of processing power for generating ... Ultrasonix imaging systems provide excellent image quality ... Pulsed Doppler, Color Doppler Color Angio, Color ...
Protects the eye during or after surgery or trauma. Clear window dressing. Protects the eye allowing the patient to see....
Medicine Products: